|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Liver Diseases | |||||
| 2 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Choline Chloride | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Choline | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antilipemic Agents | |||||
| Antimetabolites | |||||
| Central Nervous System Agents | |||||
| Gastrointestinal Agents | |||||
| Lipotropic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nootropic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| FDA Office of Orphan Products Development | |||||